Investigating the roles of tau protein, amyloid beta, and APOE in Alzheimer's disease

Dynamics of Tau protein, Amyloid beta oligomer, and APOE isoforms at the neurovascular unit

NIH-funded research University of Rochester · NIH-10710705

This study is looking at how certain proteins related to Alzheimer's disease affect brain health and blood flow, with the goal of finding new ways to help people with the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Rochester NIH-funded
Lab location1 site (Rochester, United States)
Project IDNIH-10710705 on NIH RePORTER

What this research studies

This research focuses on understanding how tau protein, amyloid beta oligomers, and APOE4 interact at the neurovascular unit, which is crucial for brain health. Using a specialized in vitro platform called µSiM-hNVU, the study examines how these proteins contribute to blood-brain barrier dysfunction and neuroinflammation in Alzheimer's disease. By observing these interactions in real-time, researchers aim to uncover mechanisms that could lead to new therapeutic strategies for Alzheimer's patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk due to genetic factors like APOE4.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results using similar in vitro platforms to study neurovascular interactions in neurodegenerative diseases.

Where this research is happening

Rochester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.